Skip Navigation U.S. Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
www.ahrq.gov

Table 175
Percent of patients with adverse drug events: anticoagulant-related warfarin, United States, 2005a
Population group Percent SE
Total   6.89 0.41
Age Under 65 6.58 1.30
65-74 7.28 0.75
75-84 6.64 0.62
85 and over 6.97 0.99
Gender Female 6.98 0.55
Male 6.77 0.61
Race White 6.92 0.43
Black 6.64 1.56
Other * *
Diabetes Yes 7.21 0.74
No 6.74 0.49
Obesity Yes 8.51 1.27
No 6.66 0.43
Cerebrovascular disease Yes 7.97 0.84
No 6.49 0.46
CHF/pulmonary edema Yes 7.55 0.66
No 6.41 0.52
COPD Yes 7.77 0.77
No 6.48 0.48
Smoking Yes 6.79 1.29
No 6.90 0.43
Corticosteroids Yes 10.86 1.66
No 6.49 0.42
Coronary artery disease Yes 6.75 0.58
No 7.01 0.57
Renal disease Yes 11.31 1.00
No 5.32 0.42

a Data include Medicare beneficiaries discharged from January to December.

* Data do not meet the criteria for statistical reliability, data quality, or confidentiality.

Key: CHF: congestive heart failure; COPD: chronic obstructive pulmonary disease; SE: standard error.

Source: Centers for Medicare & Medicaid Services, Medicare Patient Safety Monitoring System.

 

AHRQ Advancing Excellence in Health Care